Shire Sues Natco Pharma Over ANDA For Fosrenol

Law360, New York (April 2, 2009, 12:00 AM EDT) -- Shire PLC has sued Natco Pharma Ltd. of India over its efforts to make a generic version of Fosrenol, marking the third suit filed in less than three weeks over patents for the kidney failure treatment.

The Ireland-based drugmaker said Thursday it had filed suit in the U.S. District Court for the Southern District of New York in response to Natco's regulatory application to sell the generic version in three dosage forms.

Shire filed suit after it received a Paragraph IV notification letter from Natco related...
To view the full article, register now.